Health Lean Analytics (HLA), a startup based in Barcelona, has successfully raised €2.1 million in funding to advance its medical technology solutions tailored specifically for hospitals. The funding comprises a €1.4 million seed investment led by Inderhabs, Namarel, and Braincats family offices, alongside a loan from ENISA, part of the Spanish Ministry of Industry, Trade and Tourism. This additional infusion of capital positions the company to expand its technological footprint and explore new markets.
What Does HLA’s Technology Offer?
HLA focuses on automating data collection in hospitals, aiming to improve operational efficiency and the quality of patient care. By utilizing IoT, advanced analytics, and AI, the company specifically targets the high-pressure environment of the surgical suite. Here, its solutions passively capture data in real-time without burdening healthcare workers. The technology integrates with existing systems to consolidate information on patient care, resources, and operating room logistics.
How Will the Partnership with Novanta Influence HLA?
The introduction of Novanta as a technology partner brings further opportunities for HLA. Novanta’s expertise in advanced manufacturing and access to the US market serves as a critical boost. This partnership also provides HLA with increased resources and expertise, which will be instrumental in scaling their solutions. Mauro Batesteza, co-founder and co-CEO of HLA, mentioned the significance of this collaboration to propel R&D innovation and commercial deployment.
“With this support, we will be able to initiate commercial deployment in the United States, a key market, and demonstrate how our technology transforms hospital management by increasing efficiency, safety and quality of patient care.”
John Lesica, Co-Chief Operating Officer of Novanta, commented on the potential of HLA’s AI and analytics platform to reshape hospital operations. The seamless integration between Novanta’s RFID and sensing technologies and HLA’s platform underlines the synergies at play.
“Together, we’re closing the loop between physical hospital workflows and intelligent decision-making,” he said, emphasizing the goal of enhancing operating room procedures.
This news follows similar endeavors in the healthcare technology sector, where numerous companies are seeking to optimize hospital operations through AI and data-driven solutions. However, HLA’s emphasis on fully automated, real-time data capture sets it apart, addressing longstanding challenges hospitals face in managing complex surgical environments.
Proceeds from this funding will facilitate HLA’s international growth, with the United States identified as a primary target. An investment in R&D will be pivotal to refine and differentiate their offerings further. Over the coming year, the planned commercial deployment will mark a pivotal step in HLA’s journey to validate its innovative solutions in a demanding market.
With data automation technologies rapidly transforming healthcare, HLA’s endeavor to integrate real-time analytics into hospital systems reflects a broader industry trend. Such systems have the potential not only to enhance operational efficiency but also to positively impact patient outcomes. As healthcare environments become increasingly data-centric, solutions like those offered by HLA could play a key role in future hospital management practices.
